ASPIRUS WAUSAU HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $1.2M
- Transactions
- 305
- Companies
- 40
- Average per transaction
- $3,889
Who reported the payments
| Orthofix Medical, Inc. | $477,321 |
| Cardiofocus, Inc. | $300,000 |
| Olympus America Inc. | $84,771 |
| Genentech, Inc. | $42,821 |
| Pfizer | $28,400 |
| Atricure, Inc. | $19,008 |
| Novartis | $16,500 |
| AstraZeneca | $15,750 |
| Siemens Medical Solutions USA, Inc. | $14,623 |
| Linvatec Corporation | $11,980 |
| KARL Storz Endoscopy-america | $10,820 |
| Intuitive Surgical | $10,672 |
| Abbott | $9,633 |
| Merck | $9,346 |
| Medline Industries LP | $7,955 |
| E.r. Squibb & Sons, L.L.C. | $7,750 |
| Johnson & Johnson | $7,613 |
| Arjo Inc. | $7,500 |
| Boehringer Ingelheim | $7,500 |
| Amgen | $6,750 |
| Genentech USA, Inc. | $6,500 |
| AbbVie | $6,250 |
| Edwards Lifesciences | $5,000 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | $4,500 |
| Bayer | $3,750 |
| Takeda Pharmaceuticals U.S.A., Inc. | $3,500 |
| Daiichi Sankyo Inc. | $3,000 |
| Lilly USA, LLC | $3,000 |
| Boston Scientific | $3,000 |
| Novocure Inc. | $3,000 |
| Actelion Pharmaceuticals US, Inc. | $3,000 |
| Sanofi-aventis U.S. LLC | $3,000 |
| Novo Nordisk | $3,000 |
| Regeneron Healthcare Solutions, Inc. | $3,000 |
| Astellas Pharma US Inc | $3,000 |
| Gilead | $2,500 |
| Sanofi | $2,500 |
| Rigel Pharmaceuticals, Inc. | $2,250 |
| Taiho Oncology, Inc. | $2,250 |
| Eisai Inc. | $1,750 |